Clusterin , a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis

Beny Shapiro; Piera Tocci; Gal Haase; Nancy Gavert; Avri Ben-Ze’ev

doi:10.18632/oncotarget.5360

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis

Beny Shapiro, Piera Tocci, Gal Haase, Nancy Gavert and Avri Ben-Ze’ev _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:34389-34401. https://doi.org/10.18632/oncotarget.5360

Metrics: PDF 2302 views | HTML 3178 views | ?

Abstract

Beny Shapiro1,*, Piera Tocci1,*, Gal Haase1, Nancy Gavert1, Avri Ben-Ze’ev1

1Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, 76100, Israel

*These authors have equally contributed to this work

Correspondence to:

Avri Ben-Ze’ev, e-mail: [email protected]

Keywords: clusterin, L1, colon cancer, metastasis

Received: May 12, 2015 Accepted: September 07, 2015 Published: September 19, 2015

ABSTRACT

Hyperactive Wnt signaling is a common feature in human colorectal cancer (CRC) cells. A central question is the identification and role of Wnt/β-catenin target genes in CRC and their relationship to genes enriched in colonic stem cells, since Lgr5+ intestinal stem cells were suggested to be the cell of CRC origin. Previously, we identified the neural immunoglobulin-like adhesion receptor L1 as a Wnt/β-catenin target gene localized in cells at the invasive front of CRC tissue and showed that L1 expression in CRC cells confers enhanced motility and liver metastasis. Here, we identified the clusterin (CLU) gene that is also enriched in Lgr5+ intestinal stem cells, as a gene induced during L1-mediated CRC metastasis. The increase in CLU levels by L1 in CRC cells resulted from transactivation of CLU by STAT-1. CLU overexpression in CRC cells enhanced their motility and the reduction in CLU levels in L1 overexpressing cells suppressed the ability of L1 to confer increased tumorigenesis and liver metastasis. Genes induced during L1-mediated CRC cell metastasis and enriched in intestinal stem cells might be important for both CRC progression and colonic epithelium homeostasis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 5360

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis

Abstract